Journal article
Economic impact of pneumococcal protein-D conjugate vaccine (PHiD-CV) on the Malaysian National Immunization Programme
This study assesses the cost-effectiveness of introducing pneumococcal polysaccharide and nontypeable Haemophilus influenzae protein D conjugate vaccine (PHiD-CV) in the National Immunization Programme of Malaysia. It compares introducing PHiD-CV (10 valent vaccine) with current no vaccination, as well as against the alternative 13-valent pneumococcal conjugate vaccine (PCV13).
Authors
Languages
- English
Publication year
2014
Journal
Value in Health Regional Issues
Volume
3
Type
Categories
Diseases
Countries
Organisations
WHO Regions
